Skip to main content
Nutex Health, Inc. logo

Nutex Health, Inc. — Investor Relations & Filings

Ticker · NUTX ISIN · US18727D1054 LEI · 254900RSD2OET3HENJ50 US Human health and social work activities
Open in API
Filings indexed 489 across all filing types
Latest filing 2024-02-29 Board/Management Inform…
Country US United States of America
Listing US NUTX

About Nutex Health, Inc.

https://www.nutexhealth.com/

Nutex Health, Inc. is a physician-led healthcare management and operations company structured into two core divisions: a Hospital Division and a Population Health Management Division. The Hospital Division develops, owns, and operates a network of facilities, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). These facilities provide 24/7 emergency services, inpatient care, and specialized treatments such as behavioral health and detoxification. The Population Health Management Division owns and operates provider networks, such as Independent Physician Associations (IPAs), and provides comprehensive administrative and management support to physician groups through its Management Services Organizations (MSOs), aiming to improve care delivery and operational efficiency.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 29, 2024, reporting changes in the company's board of directors. It details the departure of one director and the appointment of another. There are no financial statements or earnings data presented. The primary content is about board membership changes, which aligns with announcements of changes in the company's board or senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is just over 5,000 characters, and it contains substantive information about management changes, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2024-02-29 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the termination of a material definitive agreement related to a Pre-Paid Advance Agreement, detailing the financial terms and the payoff of the remaining balance. There are no financial statements or comprehensive financial data presented, only a disclosure of a financing agreement termination. The document length is 4590 characters, which is relatively short and focused on a specific event. This fits the category of a Capital/Financing Update (CAP), as it provides an update on the company's financing activities and capital structure changes. It is not an earnings release, annual report, or other types of filings. Therefore, the appropriate classification is CAP with high confidence.
2024-02-15 English
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 8, 2024, for Nutex Health Inc. The key content is the announcement of a change in the CEO's compensation (salary reduction) and an addendum to the employment agreement. This fits the category of announcements related to changes in senior management or board members. There are no financial statements or detailed financial data, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement or regulatory filing of a different nature. The document clearly falls under Board/Management Information (MANG) as it announces a management compensation change and employment agreement update.
2024-02-09 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus supplement and accompanying prospectus filed pursuant to Rule 424(b)(5) under a shelf registration statement (Form S-3). It describes an offering of common stock and warrants, including terms, pricing, use of proceeds, risk factors, and plan of distribution. The document is focused on capital raising activities and securities issuance. It is not a financial report, earnings release, management discussion, or regulatory filing unrelated to capital raising. The presence of detailed offering terms, pricing, and placement agent information clearly identifies this as a capital/financing update. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a high confidence score.
2024-01-24 English
FORM 8-K
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC by Nutex Health Inc. dated January 22, 2024. It reports the entry into a material definitive agreement involving a securities purchase agreement and placement agency agreement for a capital raise of approximately $10 million. The document details the terms of the securities offering, warrants, and placement fees. It also references related exhibits and supplemental risk factors. The content focuses on financing activities and capital structure changes rather than financial results, management changes, or other report types. Therefore, this filing is best classified as a Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement but a substantive filing about financing.
2024-01-24 English
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Nutex Health, Inc. It announces that the company's CEO and President will present at the 42nd Annual J.P. Morgan Healthcare Conference and includes the investor presentation as an exhibit (Exhibit 99.1). The text explicitly states that the presentation is furnished as an exhibit and is not considered filed for certain regulatory purposes. The document length is 3704 characters, which is relatively short and primarily serves as an announcement of the presentation rather than the presentation itself. Therefore, this document is best classified as an Investor Presentation (IP) filing type, as it contains the presentation material for investors focusing on financials, strategy, and market position.
2024-01-11 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.